Leucettinib-21, a DYRK1A inhibitor drug candidate aiming at the correction of cognitive disorders in people with Down syndrome or Alzheimer’s disease

titleLeucettinib-21, a DYRK1A inhibitor drug candidate aiming at the correction of cognitive disorders in people with Down syndrome or Alzheimer’s disease
start_date2023/09/28
schedule11h30-12h30
onlineno
location_infoAmphithéâtre Serge Kampf
responsiblesSadoul

Workflow history

from state (1)to statecommentdate
submittedpublished2023/09/27 14:03 UTC
speakers
Meijer
Event #730798 - latest update on 2023/09/27, created on 2023/09/27